3D Cell Culture Market
Market Insights on 3D Cell Culture covering sales outlook, demand forecast & up-to-date key trends
3D Cell Culture Market By Product (Scaffold-free, Scaffold-based), Application (Drug Discovery, Tissue Regeneration & Regenerative Methods, Cancer Research, Stem Cell Technology), End User (Biotechnology & Pharmaceutical Industries, Hospital Laboratories, Academic Research & Institutes, Contract Research Organizations) & Region - Forecast 2022 - 2031
3D Cell Culture Market Outlook (2022-2031)
[253 Pages Report] The global 3D cell culture market stands at a net worth of US$ 1.15 Bn in 2022, and is predicted to surge ahead at a CAGR of 9.8% over the forecast period to attain a valuation of US$ 2.67 Bn by 2031.
3D Cell Culture Market Size (2022) |
US$ 1.15 Bn |
Sales Forecast (2031) |
US$ 2.67 Bn |
Global Market Growth Rate (2022 to 2031) |
9.8% CAGR |
Share of Top 5 Market Players |
55% |
3D cell culture accounted for 4.8% share of the global cell culture market in 2021.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
Particulars |
Details |
H1, 2021 |
9.67% |
H1, 2022 Projected |
9.79% |
H1, 2022 Outlook |
9.69% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 |
(+) 02 ↑ |
The comparative analysis and market growth rate of global 3D cell culture market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS).
The market observes a drop in the BPS values owed to the disadvantage of the 3D cell culture as compared to surface 2D cultures during the mass transfer process, thus making it a time consuming and cost incurring factor for manufacturers.
Conversely, there is presented, a surge in the BPS value by 02 points indicating positive market outlook. The rise in the BPS values is associated with the adoption of innovative cell culture devices for more predictive 3D models, thus promoting cost reduction, and limiting production times.
The market is subject to changes as per the drug development and regulatory impositions, in regard to the macro and industry based dynamics.
Key development in the market includes the incorporation of scaffold-free 3D systems for stem-cell derived therapies.
3D Cell Culture Demand Analysis from 2016 to 2021 Vs Future Market Outlook for 2022 to 2031
“Increasing R&D Activities in 3D Cell Culture Driving Market Growth”
During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%.
3D cell culture creates an artificial environment for the growth of cells to study their behavior in response to the given environment. 3D cell culture can be defined as the culture of living cells that form a three-dimensional structure and mimic a tissue or an organ.
3D cell culture is highly used for its convenience and innovative features as compared to other cell culture methods. 3D cell culture can be scaffold-free or scaffold-based 3D cell culture. Scaffolds are responsible for providing support to the cells.
Increasing focus on discovering alternatives to animal testing, expanding focus on customized therapy, growing prevalence of chronic diseases, and increasing availability of research funding are all driving this market forward.
The global 3D cell culture market is anticipated to surge ahead at a CAGR of 9.8% from 2022 to 2031.
What Key Factors are Driving Demand for 3D Cell Culture?
“Increasing Focus on Developing Alternatives to Animal Testing Driving Demand for 3D Cell Culture Products”
3D cell culture is a suitable alternative in translational and regenerative medicine since its represents a new, advanced, and robust platform for the investigation of complex biological procedures. 3D cell culture is projected to extend to various sectors of scientific research.
Tissue divergence and cell cohesion are improved in 3D cell culture. 3D cell culture products are becoming more popular and have more applications, particularly in the early stages of drug development and other research & innovation.
Researchers employ this technology to create physiologically comparable cell cultures that help in drug development and discovery. The constant desire to improve efficiency in pharmaceutical R&D is also promoting the adoption of 3D cell culture products.
Increased focus on exploring options for animal testing is expected to boost market expansion.This is due to regulatory bodies' increased efforts to replace, reduce, and refine animals used in tests, as well as to provide rehabilitation for those animals. Non-animal models efficiently convert toxicological and pharmacology data to humans are also predicted to support demand for alternatives to animal testing.
Researchers are undertaking tests to advance and create better options for cultivating cells, and 3D cell culture offers a number of advantages, including improved information and the ability to perform more effective research.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Challenging Factors for 3D Cell Culture Market Expansion?
“High Costs & Difficulty in Replicating Cells in Microenvironments”
3D cell culture is expensive, which discourages end users from purchasing the equipment. Furthermore, high expenses associated with assay validation, linkage to previous 2D culture findings, and analytical methodologies are all legitimate concerns.
Another major barrier to the adoption of 3D cell culture techniques is the lack of consistency between wells and batches of cell culture. When it comes to putting scaffold/ECM into microplate wells, researchers face a number of challenges.
This variability in products lowers the reproducibility of outcomes, and, as a result, lowers research efficiency.
Which Region is Expected to Lead the Global Market for 3D Cell Culture?
“Rising Investments for Development of 3D Cell Culture Models in North America”
North America is likely to hold the largest share of the global market because of growing incidence of cancer and the presence of a well-established pharmaceutical and biotechnology sector in the region.
Increasing investments for the development of advanced 3D cell culture models, high healthcare expenditure, and the existence of several universities and research organizations investigating various stem cell-based approaches are factors supporting market expansion in North America.

A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Analysis
Why is the U.S. 3D Cell Culture Market Growing at a Rapid Pace?
“Continuous Advancements in 3D Cell Technology to Augment Market Growth”
In the United States, key firms are focusing on R&D and investing significantly in 3D cell technology research. Rising investments in the biomedical engineering sector are driving market growth in the country.
Many Americans are among the top patent applicants in the field of 3D cell technology. American applicants are more likely to develop their technology in the country. Many contract research groups work on a range of initiatives in oncology, stem cells, and regenerative medicine in the U.S.
Why is Demand for 3D Cell Culture Surging in China?
“Growing Demand for Regenerative Medicines in China”
The market in China is speculated to exhibit high growth owing to government support & strategic initiatives. China is putting greater emphasis on technology improvements in order to cater to the large patient base.
Rise in the number of senior individuals as well as high cancer incidence has resulted in higher demand for innovative treatments and cures. Market expansion in China is being driven by progress in the field of regenerative medicine as well as a well-developed healthcare infrastructure.
Category-wise Insights
Which Product Accounts for Highest Revenue Generation?
“Scaffold-based 3D Cell Culture Gaining Popularity in Providing Structural Support for Cell Attachment”
The advantages of scaffolds in 3D cell culture, such as structural stiffness and attachment sites, have had a significant impact on the demand for scaffold-based 3D cell culture, securing a big portion of the market.
In 3D cell culture-based research, use of hydrogels as scaffolds allows for the insertion of advanced biochemical and mechanical indications as a mirror of the original extracellular matrix.
Furthermore, introduction of new products and growing demand for hydrogel developments to provide stable platforms for studying human and cellular physiology are projected to drive market growth in the future years.
Nanofiber-based scaffolds are expected to benefit from increased awareness and acceptance of nanotechnology in biomedical research, resulting in increased sales and demand for scaffold-based 3D cell culture.
Which Sector is the Dominant End User of 3D Cell Culture?
“Biotechnology & Pharmaceutical Industries Seeing Rapid Adoption of 3D Cell Culture for Drug Discovery”
Biotechnology and pharmaceutical industries are expected to account for 43.8% share of the therapeutic nuclear medicines market in 2022. Primary market drivers include the presence of a large number of biotechnology and pharmaceutical industries, growth in R&D spending in these companies, and growing preference for alternative testing models over animal approaches.
In comparison to 2D cell culture, 3D cell culture has benefits in terms of appropriate oxygen and nutritional gradients, non-uniform access of cells within a spheroid to a drug, and realistic cell-to-cell interactions. As a result of these variables, 3D cell culture is better suited for drug discovery and development, resulting in increased demand.
COVID-19 Impact on 3D Cell Culture Demand
The COVID-19 pandemic had an impact on a variety of businesses around the world. During the early phases of the pandemic, manufacturing facilities all around the world were shut down. Furthermore, the financial downturn that followed the pandemic could cause a major delay in the commercialization of the healthcare industry.
On the other hand, small manufacturers and entrepreneurs have a lot of potential in the 3D cell culture market to come up with cost-effective solutions for producing 3D cell culture products. There is steady increase in demand from clinical and diagnostic centers, which may drive various companies to enter this market with unique products.
Competitive Landscape
Key 3D cell culture providers are innovating in products and focusing on new launches. Prominent manufacturers of 3D cell culture are offering a wide range of products.
For instance,
- Thermo Fisher Scientific, Inc. has developed a joint platform for advancing research in precision medicine.
- Corning, one of the major leaders in the market, manufactures cell culture products that include consumables, as well as general labware and equipment, which are used for advanced cell culture research.
3D Cell Culture Industry Report Scope
Attribute |
Details |
Forecast Period |
2022-2031 |
Historical Data Available for |
2016-2021 |
Market Analysis |
Value in US$ Mn |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing |
Available upon Request |
Key Segments of 3D Cell Culture Industry Survey
3D Cell Culture Market by Product:
- Scaffold-free 3D Cell Culture
- Scaffold-based 3D Cell Culture
3D Cell Culture Market by Application:
- Drug Discovery
- Tissue Regeneration & Regenerative Methods
- Cancer Research
- Stem Cell Technology
- Others
3D Cell Culture Market by End User:
- Biotechnology and Pharmaceutical Industries
- Hospital Laboratories
- Academic Research and Institutes
- Contract Research Organizations
3D Cell Culture Market by Region:
- North America 3D Cell Culture Market
- Latin America 3D Cell Culture Market
- Europe 3D Cell Culture Market
- East Asia 3D Cell Culture Market
- South Asia & Pacific 3D Cell Culture Market
- Middle East & Africa (MEA) 3D Cell Culture Market
Frequently Asked Questions
The global 3D cell culture market is expected to reach US$ 1.15 Bn in 2022.
Top companies in the 3D cell culture market are 3D Biotek LLC, Advanced Biomatrix Inc., Thermo Fisher Scientific Inc., Kuraray Co. Ltd., and Lonza Group Ltd.
The global market is estimated to exhibit a CAGR of 9.8% during the forecast period (2022-2031).
Alarming rate of cancers worldwide and approval of the use of 3D cell culture by government bodies are major factors driving market expansion.
Biotechnology and pharmaceutical industries account for 43.8% share of the 3D cell culture market.
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Exclusion and Inclusion
3. Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Trends
5. Key Inclusions
5.1. Regulations and Guidelines
5.2. Regulatory Scenario
5.3. Value Chain
5.4. Product Mapping
5.5. Pricing Analysis
6. Global Economic Outlook
7. North America Market Analysis 2016-2021 and Forecast 2022-2031
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2021
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2022-2031
7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
7.4.1. Scaffold-Free 3D Cell Culture
7.4.2. Scaffold-Based 3D Cell Culture
7.4.2.1. Hydrogel-based
7.4.2.2. Polymeric hard material based
7.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
7.6. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
7.6.1. Drug Discovery
7.6.2. Tissue Regeneration & Regenerative Medicines
7.6.3. Cancer Research
7.6.4. Stem Cell Technology
7.6.5. Others
7.7. Market Size (US$ Mn) Forecast By Applications, 2022-2031
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
7.8.1. Biotechnology and Pharmaceuticals Industries
7.8.2. Hospital Laboratories
7.8.3. Academic Research Institutes
7.8.4. Contract Research Organizations
7.9. Market Size (US$ Mn) Forecast By End User, 2022-2031
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By Applications
7.10.4. By End User
7.11. Drivers and Restraints: Impact Analysis
8. Latin America Market Analysis 2016-2021 and Forecast 2022-2031
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2021
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Argentina
8.2.4. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2022-2031
8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
8.4.1. Scaffold-Free 3D Cell Culture
8.4.2. Scaffold-Based 3D Cell Culture
8.4.2.1. Hydrogel-based
8.4.2.2. Polymeric hard material based
8.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
8.6. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
8.6.1. Drug Discovery
8.6.2. Tissue Regeneration & Regenerative Medicines
8.6.3. Cancer Research
8.6.4. Stem Cell Technology
8.6.5. Others
8.7. Market Size (US$ Mn) Forecast By Applications, 2022-2031
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
8.8.1. Biotechnology and Pharmaceuticals Industries
8.8.2. Hospital Laboratories
8.8.3. Academic Research Institutes
8.8.4. Contract Research Organizations
8.9. Market Size (US$ Mn) Forecast By End User, 2022-2031
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Applications
8.10.4. By End User
8.11. Drivers and Restraints: Impact Analysis
9. Western Europe Market Analysis 2016-2021 and Forecast 2022-2031
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2021
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2022-2031
9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
9.4.1. Scaffold-Free 3D Cell Culture
9.4.2. Scaffold-Based 3D Cell Culture
9.4.2.1. Hydrogel-based
9.4.2.2. Polymeric hard material based
9.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
9.6. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
9.6.1. Drug Discovery
9.6.2. Tissue Regeneration & Regenerative Medicines
9.6.3. Cancer Research
9.6.4. Stem Cell Technology
9.6.5. Others
9.7. Market Size (US$ Mn) Forecast By Applications, 2022-2031
9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
9.8.1. Biotechnology and Pharmaceuticals Industries
9.8.2. Hospital Laboratories
9.8.3. Academic Research Institutes
9.8.4. Contract Research Organizations
9.9. Market Size (US$ Mn) Forecast By End User, 2022-2031
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Applications
9.10.4. By End User
9.11. Drivers and Restraints: Impact Analysis
10. Eastern Europe Market Analysis 2016-2021 and Forecast 2022-2031
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2021
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2022-2031
10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
10.4.1. Scaffold-Free 3D Cell Culture
10.4.2. Scaffold-Based 3D Cell Culture
10.4.2.1. Hydrogel-based
10.4.2.2. Polymeric hard material based
10.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
10.6. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
10.6.1. Drug Discovery
10.6.2. Tissue Regeneration & Regenerative Medicines
10.6.3. Cancer Research
10.6.4. Stem Cell Technology
10.6.5. Others
10.7. Market Size (US$ Mn) Forecast By Applications, 2022-2031
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
10.8.1. Biotechnology and Pharmaceuticals Industries
10.8.2. Hospital Laboratories
10.8.3. Academic Research Institutes
10.8.4. Contract Research Organizations
10.9. Market Size (US$ Mn) Forecast By End User, 2022-2031
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Applications
10.10.4. By End User
10.11. Drivers and Restraints: Impact Analysis
11. Asia Pacific Excluding Japan Market Analysis 2016-2021 and Forecast 2022-2031
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2021
11.2.1. India
11.2.2. Australia and New Zealand
11.2.3. ASEAN
11.2.4. China
11.2.5. Rest of APEJ
11.3. Market Size (US$ Mn) Forecast By Country, 2022-2031
11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
11.4.1. Scaffold-Free 3D Cell Culture
11.4.2. Scaffold-Based 3D Cell Culture
11.4.2.1. Hydrogel-based
11.4.2.2. Polymeric hard material based
11.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
11.6. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
11.6.1. Drug Discovery
11.6.2. Tissue Regeneration & Regenerative Medicines
11.6.3. Cancer Research
11.6.4. Stem Cell Technology
11.6.5. Others
11.7. Market Size (US$ Mn) Forecast By Applications, 2022-2031
11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
11.8.1. Biotechnology and Pharmaceuticals Industries
11.8.2. Hospital Laboratories
11.8.3. Academic Research Institutes
11.8.4. Contract Research Organizations
11.9. Market Size (US$ Mn) Forecast By End User, 2022-2031
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Applications
11.10.4. By End User
11.11. Drivers and Restraints: Impact Analysis
12. Japan Market Analysis 2016-2021 and Forecast 2022-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
12.2.1. Scaffold-Free 3D Cell Culture
12.2.2. Scaffold-Based 3D Cell Culture
12.2.2.1. Hydrogel-based
12.2.2.2. Polymeric hard material based
12.3. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
12.4. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
12.4.1. Drug Discovery
12.4.2. Tissue Regeneration & Regenerative Medicines
12.4.3. Cancer Research
12.4.4. Stem Cell Technology
12.4.5. Others
12.5. Market Size (US$ Mn) Forecast By Applications, 2022-2031
12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
12.6.1. Biotechnology and Pharmaceuticals Industries
12.6.2. Hospital Laboratories
12.6.3. Academic Research Institutes
12.6.4. Contract Research Organizations
12.7. Market Size (US$ Mn) Forecast By End User, 2022-2031
12.8. Market Attractiveness Analysis
12.8.1. By Product Type
12.8.2. By Applications
12.8.3. By End User
12.9. Drivers and Restraints: Impact Analysis
13. Middle East and Africa Market Analysis 2016-2021 and Forecast 2022-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2021
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of Middle East and Africa
13.3. Market Size (US$ Mn) Forecast By Country, 2022-2031
13.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
13.4.1. Scaffold-Free 3D Cell Culture
13.4.2. Scaffold-Based 3D Cell Culture
13.4.2.1. Hydrogel-based
13.4.2.2. Polymeric hard material based
13.5. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
13.6. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
13.6.1. Drug Discovery
13.6.2. Tissue Regeneration & Regenerative Medicines
13.6.3. Cancer Research
13.6.4. Stem Cell Technology
13.6.5. Others
13.7. Market Size (US$ Mn) Forecast By Applications, 2022-2031
13.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
13.8.1. Biotechnology and Pharmaceuticals Industries
13.8.2. Hospital Laboratories
13.8.3. Academic Research Institutes
13.8.4. Contract Research Organizations
13.9. Market Size (US$ Mn) Forecast By End User, 2022-2031
13.10. Market Attractiveness Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Applications
13.10.4. By End User
13.11. Drivers and Restraints: Impact Analysis
14. Forecast Factors: Relevance and Impact
15. Company Share Analysis
15.1. Market Structure Analysis
15.2. Market Share Analysis, 2022
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Deep Dive
16.2.1. Thermo Fisher Scientific Inc.
16.2.1.1. Overview
16.2.1.2. Analyst Commentary
16.2.1.3. Channel Footprint
16.2.1.4. Strategy
16.2.2. Merck KGaA
16.2.2.1. Overview
16.2.2.2. Analyst Commentary
16.2.2.3. Channel Footprint
16.2.2.4. Strategy
16.2.3. Becton, Dickinson and Company
16.2.3.1. Overview
16.2.3.2. Analyst Commentary
16.2.3.3. Channel Footprint
16.2.3.4. Strategy
16.2.4. Lonza
16.2.4.1. Overview
16.2.4.2. Analyst Commentary
16.2.4.3. Channel Footprint
16.2.4.4. Strategy
16.2.5. Corning Incorporated
16.2.5.1. Overview
16.2.5.2. Analyst Commentary
16.2.5.3. Channel Footprint
16.2.5.4. Strategy
16.2.6. Synthecon, Inc
16.2.6.1. Overview
16.2.6.2. Analyst Commentary
16.2.6.3. Channel Footprint
16.2.6.4. Strategy
16.2.7. 3D Biotek LLC
16.2.7.1. Overview
16.2.7.2. Analyst Commentary
16.2.7.3. Channel Footprint
16.2.7.4. Strategy
16.2.8. Nanofiber Solutions, Inc.
16.2.8.1. Overview
16.2.8.2. Analyst Commentary
16.2.8.3. Channel Footprint
16.2.8.4. Strategy
16.2.9. Greiner Group A
16.2.9.1. Overview
16.2.9.2. Analyst Commentary
16.2.9.3. Channel Footprint
16.2.9.4. Strategy
16.2.10. Lena Biosciences
16.2.10.1. Overview
16.2.10.2. Analyst Commentary
16.2.10.3. Channel Footprint
16.2.10.4. Strategy
16.2.11. REPROCELL
16.2.11.1. Overview
16.2.11.2. Analyst Commentary
16.2.11.3. Channel Footprint
16.2.11.4. Strategy
16.2.12. MicroTissues, Inc.
16.2.12.1. Overview
16.2.12.2. Analyst Commentary
16.2.12.3. Channel Footprint
16.2.12.4. Strategy
17. Global Market Analysis 2016-2021 and Forecast 2022-2031 By Region
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Mn) Analysis By Region
17.2.1. North America
17.2.2. Latin America
17.2.3. Western Europe
17.2.4. Eastern Europe
17.2.5. Asia Pacific Excluding Japan
17.2.6. Japan
17.2.7. Middle East and Africa
17.3. Market Size (US$ Mn) Forecast By Region
17.4. Market Attractiveness Analysis By Region
18. Global Market Analysis 2016-2021 and Forecast 2022-2031, By Product Type
18.1. Introduction/Key Finding
18.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016-2021
18.2.1. Scaffold-Free 3D Cell Culture
18.2.2. Scaffold-Based 3D Cell Culture
18.2.2.1. Hydrogel-based
18.2.2.2. Polymeric hard material based
18.2.3. Market Size (US$ Mn) Forecast By Product Type, 2022-2031
18.2.4. Market Attractiveness Analysis By Product Type
19. Global Market Analysis 2016-2021 and Forecast 2022-2031, By Applications
19.1. Introduction/Key Finding
19.2. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2016-2021
19.2.1. Drug Discovery
19.2.2. Tissue Regeneration & Regenerative Medicines
19.2.3. Cancer Research
19.2.4. Stem Cell Technology
19.2.5. Others
19.3. Market Size (US$ Mn) Forecast By Applications, 2022-2031
19.4. Market Attractiveness Analysis By Applications
20. Global Market Analysis 2016-2021 and Forecast 2022-2031, By End User
20.1. Introduction/Key Finding
20.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016-2021
20.2.1. Biotechnology and Pharmaceuticals Industries
20.2.2. Hospital Laboratories
20.2.3. Academic Research Institutes
20.2.4. Contract Research Organizations
20.3. Market Size (US$ Mn) Forecast By End User, 2022-2031
20.4. Market Attractiveness Analysis By End User
21. Global Market Analysis 2016-2021 and Forecast 2022-2031
21.1. Market Value Share Analysis By All Segment
21.2. Y-o-Y Growth Analysis By All Segment
21.3. Absolute $ Opportunity
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health (% of GDP) by Country, 2016-2021
Table 02: Expenditure on Health (% of GDP) by Country, 2016-2021
Table 03: North America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 04: North America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 05: North America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 06: North America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Table 07: Latin America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 08: Latin America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 09: Latin America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 10: Latin America Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Table 11: Western Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 12: Western Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 13: Western Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 14: Western Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Table 15: Eastern Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 16: Eastern Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 17: Eastern Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 18: Eastern Europe Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Table 19: APEJ Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 20: APEJ Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 21: APEJ Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 22: APEJ Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Table 23: Japan Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 24: Japan Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 25: Japan Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Table 26: MEA Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 27: MEA Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 28: MEA Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 29: MEA Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Table 30: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2022–2032, By Region
Table 31: Global Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Product Type
Table 32: Global Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Application
Table 33: Global Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By End Users
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Market Revenue Share by Product Type, 2022E & 2032F
Figure 02: Market Revenue Share by Application , 2022E & 2032F
Figure 03: Market Revenue Share by End Users , 2022E & 2032F
Figure 04: Market Revenue Share by Region, 2022E & 2032F
Figure 05: Number of animals used for testing in different countries
Figure 06: Impact of Drivers in 2021 and forecasted to 2032
Figure 07: Global expenditure on cell therapy in 2016 and 2021
Figure 08: Regional Average Pricing Analysis (US$) of Scaffold-Based 3D Cell Culture- Hydrogel-based (2021)
Figure 09: Regional Average Pricing Analysis (US$) of Scaffold-Based 3D Cell Culture- Polymeric hard material based (2021)
Figure 10: Regional Average Pricing Analysis (US$) of Scaffold-Free 3D Cell Culture- Bioreactor (2021)
Figure 11: World GDP (Nominal) by Selected Economies, 2021
Figure 12: Global Healthcare Expenditure in US$ Bn (2016–2020)
Figure 13: North America Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 14: North America Market Share Analysis (%), By Application, 2022 & 2032
Figure 15: North America Market Share Analysis (%), By End Users, 2022 & 2032
Figure 16: North America Market Share Analysis (%), By Country, 2022 & 2032
Figure 17: North America Market Value Analysis (US$ Mn), 2016-2021
Figure 18: North America Market Value Forecast (US$ Mn), 2022-2032
Figure 19: U.S. Market Value Analysis (US$ Mn), 2016-2021
Figure 20: U.S. Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2032
Figure 21: Canada Market Value Analysis (US$ Mn), 2016-2021
Figure 22: Canada Market Value Forecast (US$ Mn), 2022-2032
Figure 23: North America Market Attractiveness Analysis by Product Type, 2022-2032
Figure 24: North America Market Attractiveness Analysis by Application, 2022-2032
Figure 25: North America Market Attractiveness Analysis by End User, 2022-2032
Figure 26: North America Market Attractiveness Analysis by Country, 2022-2032
Figure 27: Latin America Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 28: Latin America Market Share Analysis (%), By Application, 2022 & 2032
Figure 29: Latin America Market Share Analysis (%), By End Users, 2022 & 2032
Figure 30: Latin America Market Share Analysis (%), By Country, 2022 & 2032
Figure 31: Latin America Market Value Analysis (US$ Mn), 2016-2021
Figure 32: Latin America Market Value Forecast (US$ Mn), 2022-2032
Figure 33: Brazil Market Value Analysis (US$ Mn), 2016-2021
Figure 34: Brazil Market Value Forecast (US$ Mn), 2022-2032
Figure 35: Mexico Market Value Analysis (US$ Mn), 2016-2021
Figure 36: Mexico Market Value Forecast (US$ Mn), 2022-2032
Figure 37: Argentina Market Value Analysis (US$ Mn), 2016-2021
Figure 38: Argentina Market Value Forecast (US$ Mn), 2022-2032
Figure 39: Rest of Latin America Market Value Analysis (US$ Mn), 2016-2021
Figure 40: Rest of Latin America Market Value Forecast (US$ Mn), 2022-2032
Figure 41: Latin America Market Attractiveness Analysis by Product Type, 2022-2032
Figure 42: Latin America Market Attractiveness Analysis by Application, 2022-2032
Figure 43: Latin America Market Attractiveness Analysis by End User, 2022-2032
Figure 44: Latin America Market Attractiveness Analysis by Country, 2022-2032
Figure 45: Western Europe Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 46: Western Europe Market Share Analysis (%), By Application, 2022 & 2032
Figure 47: Western Europe Market Share Analysis (%), By End Users, 2022 & 2032
Figure 48: Western Europe Market Share Analysis (%), By Country, 2022 & 2032
Figure 49: Western Europe Market Value Analysis (US$ Mn), 2016-2021
Figure 50: Western Europe Market Value Forecast (US$ Mn), 2022-2032
Figure 51: Germany Market Value Analysis (US$ Mn), 2016-2021
Figure 52: Germany Market Value Forecast (US$ Mn), 2022-2032
Figure 53: U.K. Market Value Analysis (US$ Mn), 2016-2021
Figure 54: U.K. Market Value Forecast (US$ Mn), 2022-2032
Figure 55: France Market Value Analysis (US$ Mn), 2016-2021
Figure 56: France Market Value Forecast (US$ Mn), 2022-2032
Figure 57: Italy Market Value Analysis (US$ Mn), 2016-2021
Figure 58: Italy Market Value Forecast (US$ Mn), 2022-2032
Figure 59: Spain Market Value Analysis (US$ Mn), 2016-2021
Figure 60: Spain Market Value Forecast (US$ Mn), 2022-2032
Figure 61: Rest of Western Europe Market Value Analysis (US$ Mn), 2016-2021
Figure 62: Rest of Western Europe Market Value Forecast (US$ Mn), 2022-2032
Figure 63: Western Europe Market Attractiveness Analysis by Product Type, 2022-2032
Figure 64: Western Europe Market Attractiveness Analysis by Application, 2022-2032
Figure 65: Western Europe Market Attractiveness Analysis by End User, 2022-2032
Figure 66: Western Europe Market Attractiveness Analysis by Country, 2022-2032
Figure 67: Eastern Europe Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 68: Eastern Europe Market Share Analysis (%), By Application, 2022 & 2032
Figure 69: Eastern Europe Market Share Analysis (%), By End Users, 2022 & 2032
Figure 70: Eastern Europe Market Share Analysis (%), By Country, 2022 & 2032
Figure 71: Eastern Europe Market Value Analysis (US$ Mn), 2016-2021
Figure 72: Eastern Europe Market Value Forecast (US$ Mn), 2022-2032
Figure 73: Russia Market Value Analysis (US$ Mn), 2016-2021
Figure 74: Russia Market Value Forecast (US$ Mn), 2022-2032
Figure 75: Poland Market Value Analysis (US$ Mn), 2016-2021
Figure 76: Poland Market Value Forecast (US$ Mn), 2022-2032
Figure 77: Rest of Eastern Europe Market Value Analysis (US$ Mn), 2016-2021
Figure 78: Rest of Eastern Europe Market Forecast Analysis (US$ Mn), 2022-2032
Figure 79: Eastern Europe Market Attractiveness Analysis by Product Type, 2022-2032
Figure 80: Eastern Europe Market Attractiveness Analysis by Application, 2022-2032
Figure 81: Eastern Europe Market Attractiveness Analysis by End User, 2022-2032
Figure 82: Eastern Europe Market Attractiveness Analysis by Country, 2022-2032
Figure 83: APEJ Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 84: APEJ Market Share Analysis (%), By Application, 2022 & 2032
Figure 85: APEJ Market Share Analysis (%), By End Users, 2022 & 2032
Figure 86: APEJ Market Share Analysis (%), By Country, 2022 & 2032
Figure 87: APEJ Market Value Analysis (US$ Mn), 2016-2021
Figure 88: APEJ Market Value Forecast (US$ Mn), 2022-2032
Figure 89: India Market Value Analysis (US$ Mn), 2016-2021
Figure 90: India Market Value Forecast (US$ Mn), 2022-2032
Figure 91: China Market Value Analysis (US$ Mn), 2016-2021
Figure 92: China Market Value Forecast (US$ Mn), 2022-2032
Figure 93: Australia & New Zealand Market Value Analysis (US$ Mn), 2016-2021
Figure 94: Australia & New Zealand Market Value Forecast (US$ Mn), 2022-2032
Figure 95: Rest of APEJ Market Value Analysis (US$ Mn), 2016-2021
Figure 96: Rest of APEJ Market Value Forecast (US$ Mn), 2022-2032
Figure 97: APEJ Market Attractiveness Analysis by Product Type, 2022-2032
Figure 98: APEJ Market Attractiveness Analysis by Application, 2022-2032
Figure 99: APEJ Market Attractiveness Analysis by End User, 2022-2032
Figure 100: APEJ Market Attractiveness Analysis by Country, 2022-2032
Figure 101: Japan Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 102: Japan Market Share Analysis (%), By Application, 2022 & 2032
Figure 103: Japan Market Share Analysis (%), By End User, 2022 & 2032
Figure 104: Japan Market Value Analysis (US$ Mn), 2016-2021
Figure 105: Japan Market Value Forecast (US$ Mn), 2022-2032
Figure 106: Japan Market Attractiveness Analysis by Product Type, 2022-2032
Figure 107: Japan Market Attractiveness Analysis by Application, 2022-2032
Figure 108: Japan Market Attractiveness Analysis by End Users, 2022-2032
Figure 109: MEA Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 110: MEA Market Share Analysis (%), By Application, 2022 & 2032
Figure 111: MEA Market Share Analysis (%), By End Users, 2022 & 2032
Figure 112: MEA Market Share Analysis (%), By Country, 2022 & 2032
Figure 113: MEA Market Value Analysis (US$ Mn), 2016-2021
Figure 114: MEA Market Value Forecast (US$ Mn), 2022-2032
Figure 115: GCC Countries Market Value Analysis (US$ Mn), 2016-2021
Figure 116: GCC Countries Market Value Forecast (US$ Mn), 2022-2032
Figure 117: South Africa Market Value Analysis (US$ Mn), 2016-2021
Figure 118: South Africa Market Value Forecast (US$ Mn), 2022-2032
Figure 119: Rest of MEA Market Value Analysis (US$ Mn), 2016-2021
Figure 120: Rest of MEA Market Value Forecast (US$ Mn), 2022-2032
Figure 121: MEA Market Attractiveness Analysis by Product Type, 2022-2032
Figure 122: MEA Market Attractiveness Analysis by Application, 2022-2032
Figure 123: MEA Market Attractiveness Analysis by End User, 2022-2032
Figure 124: MEA Market Attractiveness Analysis by Country, 2022-2032
Figure 125: Global Market Share Analysis (%), By Region, 2022 & 2032
Figure 126: Global Market Y-o-Y Analysis (%), By Region, 2022-2032
Figure 127: Global Market Attractiveness Analysis by Region, 2022-2032
Figure 128: Global Market Share Analysis (%), By Product Type, 2022 & 2032
Figure 129: Global Market Y-o-Y Analysis (%), By Product Type, 2022-2032
Figure 130: Global Market Value Analysis (US$ Mn) by Scaffold-Free 3D Cell Culture, 2016-2021
Figure 131: Global Market Value Analysis (US$ Mn), by Scaffold-Free 3D Cell Culture, 2022-2032
Figure 132: Global Market Value Analysis (US$ Mn), by Scaffold-Based 3D Cell Culture, 2016-2021
Figure 133: Global Market Value Analysis (US$ Mn,) by Scaffold-Based 3D Cell Culture, 2022-2032
Figure 134: Global Market Attractiveness Analysis by Product Type , 2022-2032
Figure 135: Global Market Share Analysis (%), By Application, 2022 & 2032
Figure 136: Global Market Y-o-Y Analysis (%), By Application, 2022-2032
Figure 137: Global Market Value Analysis (US$ Mn) by Drug Discovery, 2016-2021
Figure 138: Global Market Value Analysis (US$ Mn), by Drug Discovery, 2022-2032
Figure 139: Global Market Value Analysis (US$ Mn), by Tissue Regeneration & Regenerative Medicines, 2016-2021
Figure 140: Global Market Value Analysis (US$ Mn,) by Tissue Regeneration & Regenerative Medicines, 2022-2032
Figure 141: Global Market Value Analysis (US$ Mn) by Cancer Research, 2016-2021
Figure 142: Global Market Value Analysis (US$ Mn), by Cancer Research, 2022-2032
Figure 143: Global Market Value Analysis (US$ Mn), by Stem Cell Technology, 2016-2021
Figure 144: Global Market Value Analysis (US$ Mn,) by Stem Cell Technology, 2022-2032
Figure 145: Global Market Value Analysis (US$ Mn) by Others, 2016-2021
Figure 146: Global Market Value Analysis (US$ Mn), by Others, 2022-2032
Figure 147: Global Market Attractiveness Analysis by Application , 2022-2032
Figure 148: Global Market Share Analysis (%), By End Users, 2022 & 2032
Figure 149: Global Market Y-o-Y Analysis (%), By End Users, 2022-2032
Figure 150: Global Market Value Analysis (US$ Mn, by Biotechnology and Pharmaceuticals Industries, 2016-2021
Figure 151: Global Market Value Analysis (US$ Mn), by Biotechnology and Pharmaceuticals Industries, 2022-2032
Figure 152: Global Market Value Analysis (US$ Mn), by Academic Research Institutes, 2016-2021
Figure 153: Global Market Value Analysis (US$ Mn), by Academic Research Institutes, 2022-2032
Figure 154: Global Market Value Analysis (US$ Mn, by Hospital Laboratories, 2016-2021
Figure 155: Global Market Value Analysis (US$ Mn), by Hospital Laboratories, 2022-2032
Figure 156: Global Market Value Analysis (US$ Mn), by Contract Research Organizations , 2016-2021
Figure 157: Global Market Value Analysis (US$ Mn), by Contract Research Organizations , 2022-2032
Figure 158: Global Market Attractiveness Analysis by End Users , 2022-2032
Figure 159: Global Market Value Analysis (US$ Mn), 2016-2021
Figure 160: Global Market Value Forecast (US$ Mn), 2022-2032
Figure 161: Global Market Absolute $ Opportunity, 2022 - 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports